Technology
HAMILTON BEACH BRANDS HOLDING COMPANY ANNOUNCES DATES OF ITS 2026 SECOND QUARTER EARNINGS RELEASE AND CONFERENCE CALL
Published
42 minutes agoon
By
GLEN ALLEN, Va., July 29, 2026 /PRNewswire/ — Hamilton Beach Brands Holding Company (NYSE: HBB) announced today that it will release its 2026 second quarter financial results and file its 10-Q for the quarter ended June 30, 2026, after the market close on Wednesday, August 5, 2026.
The Company will host a conference call on Wednesday, August 5, 2026, to discuss its results.
Conference Call:
Wednesday, August 5, 2026
Time:
4:30 p.m. (Eastern Time)
Telephone:
833-461-5787 (toll free) International 585-542-9983
Conference ID: 561620015
(Call in at least five minutes before start time)
The conference call will be webcast live over the internet. To listen to the webcast, please select Events & Presentations from the Investors tab of the Hamilton Beach Brands Holding Company website at www.hamiltonbeachbrands.com. Please allow 15 minutes to register, download and install any necessary software. An archive of the webcast will be available on the company website.
About Hamilton Beach Brands Holding Company
Hamilton Beach Brands Holding Company is a leading designer, marketer, and distributor of a wide range of brandname small electric household and specialty housewares appliances, and commercial products for restaurants, fast food chains, bars, and hotels, and is a provider of connected devices and software for healthcare management. The Company’s owned consumer brands include Hamilton Beach®, Proctor Silex® and Weston®, as well as premium brands Hamilton Beach Professional® and Lotus®. The Company’s owned commercial brands include Hamilton Beach Commercial® and Proctor Silex Commercial®. The Company licenses the brands for CHI® premium garment care products and CloroxTM home appliances. The Company has multiyear agreements to design, sell, market, and distribute Numilk® plant-based milk makers and Sunkist® commercial juicers and sectionizers. Hamilton Beach Health, which owns HealthBeacon, is expanding the Company’s presence in the home health and medical markets through connected medical devices. For more information about Hamilton Beach Brands Holding Company, visit www.hamiltonbeachbrands.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/hamilton-beach-brands-holding-company-announces-dates-of-its-2026-second-quarter-earnings-release-and-conference-call-302837514.html
SOURCE Hamilton Beach Brands Holding Company
You may like
Technology
Cohen & Steers Closed-end Opportunity Fund, Inc. Issues Important Notice Regarding Change in Investment Policy and Investment Strategy
Published
42 minutes agoon
July 29, 2026By
NEW YORK, July 29, 2026 /PRNewswire/ — Cohen & Steers Closed-end Opportunity Fund, Inc. (NYSE:FOF) (the “Fund”), announced today that the Fund’s Board of Directors has approved certain changes to the Fund’s 80% investment policy and related investment strategy disclosure. The changes will be effective October 1, 2026 (the “Effective Time”).
At the Effective Time, the existing 80% policy will be replaced with the following new policy: Under normal circumstances, at least 80% of the Fund’s net assets will be invested in common stock or other securities issued by Portfolio Funds which are listed on a U.S. or non-U.S. securities exchange.
Additionally, at the Effective Time, the Fund’s disclosure will be revised to define “Portfolio Fund” as any closed-end pooled investment vehicle and state that the Fund will consider an investment vehicle to be “closed-end” if it does not offer a daily redemption or repurchase right. As a result of these changes, the Fund will have more flexibility under its 80% policy to invest in a broad range of U.S. and non-U.S. investment vehicles, including vehicles that are not registered under the Investment Company Act of 1940. In connection with the above changes, as of the Effective Time, the Fund is adopting the following investment strategy disclosure:
The Fund seeks to achieve its objective by investing in the common stock of closed-end pooled investment vehicles (collectively, Portfolio Funds) selected by the Fund’s investment manager that invest significantly in equity securities, income-producing securities or other assets, including precious metals and other commodities, real assets and derivatives. Portfolio Funds may invest in both publicly traded and private investments. Types or categories of Portfolio Funds may include, but are not limited to, Portfolio Funds that invest in the following asset classes:
Bank Loans;Convertible Securities;Commodities;Municipal Securities;Income Securities;High Yield Municipal Securities;MLPs;Option Income/Covered Calls;Preferred Securities;Private Credit;Private Equity;Private Real Estate;REITs and other Real Estate Securities;Short Duration Securities;Single Commodity Precious Metals;Taxable Municipal Securities;U.S. General Equity;U.S. High Yield Securities;U.S. Hybrid;U.S. Multi-Sector Securities;U.S. Sector Bond;U.S. Sector Equity;Utilities.
Shares of Portfolio Funds in which the Fund invests will be traded on a U.S. or non-U.S. securities exchange.
Securities and other investments in which Portfolio Funds are expected to focus their investments, along with equity, convertible, preferred and high yield securities and the real estate, energy and utilities sectors, are described with their accompanying risks, under “Principal Risks of the Fund—Portfolio Fund Investment Risk.”
Under normal circumstances, at least 80% of the Fund’s net assets will be invested in common stock or other securities issued by Portfolio Funds which are listed on a U.S. or non-U.S. securities exchange. The Fund will consider an investment vehicle to be “closed-end” if it does not offer a daily redemption or repurchase right. The Fund is unconstrained from an investment perspective with respect to location of Portfolio Funds (e.g., U.S. or non-U.S.), types of interests purchased by Portfolio Funds (i.e., equity or fixed income), strategy/assets held by Portfolio Funds (e.g., precious metals, municipal securities) and whether a Portfolio Fund purchases publicly or privately offered securities. Although most Portfolio Funds are expected to be registered under the 1940 Act, some will not and therefore will not provide investors, such as the Fund, with the protections of the 1940 Act. The Fund’s allocations across different types of Portfolio Funds will vary over time, perhaps significantly. The Fund also has the ability to invest directly in equity, income-producing securities, precious metals and other instruments relating to closed-end funds.
In selecting Portfolio Funds, the investment manager seeks to identify closed-end funds that meet one or more of the following characteristics:
strong fundamentals, including ability to meet current and projected future dividend payments out of current income or a combination of current income and realized and unrealized gains, and leverage/risk management, as the investment manager believes that a conservative approach to leverage has the potential to help mitigate the effects of changes in interest rates;relatively high current income;share prices at a discount to net asset value;undervalued funds where recent total return on market price trails recent total return on net asset value;well-regarded asset managers with strong track records managing the asset class(es) in which a Portfolio Fund invests;diversification of sectors and asset classes among the Portfolio Funds;market capitalization generally greater than $200 million; andaverage daily trading volumes generally greater than $750,000 per day.
There is no requirement that any Portfolio Fund in the Fund’s portfolio satisfy all the criteria set forth above, and the investment manager will use its discretion in selecting a portfolio of Portfolio Funds that the investment manager believes will help the Fund achieve its investment objective.
In addition to the criteria set forth above, the investment manager also may invest opportunistically in one or more Portfolio Funds when the investment manager believes a Portfolio Fund’s shares are not appropriately priced relative to other comparable funds or the Portfolio Fund’s share price does not properly reflect the impact of a corporate event or conditions in the overall securities markets that the investment manager believes will have a positive influence on the Portfolio Fund’s share price.
The Fund will be limited by provisions of the 1940 Act that limit the amount the Fund can invest in any one Portfolio Fund to 3% of the Portfolio Fund’s total outstanding stock. As a result, the Fund may hold a smaller position in a Portfolio Fund than if it were not subject to this restriction. To comply with provisions of the 1940 Act, on any matter upon which Portfolio Fund stockholders are solicited to vote the investment manager will vote Portfolio Fund shares in the same general proportion as shares held by other stockholders of the Portfolio Fund.
The Fund may invest in securities of other closed-end or open-end funds, including exchange traded funds (ETFs) and funds managed by the investment manager, in accordance with Section 12(d)(1) of the 1940 Act and the rules thereunder, or any exemption granted under the 1940 Act.
The Fund may, but is not required to, use, without limit, various derivatives transactions to seek to generate return, facilitate portfolio management and mitigate risks. Although the Fund’s investment manager may seek to use these kinds of transactions to further the Fund’s investment objectives, no assurance can be given that they will achieve this result. The Fund may enter into (buy or sell) exchange-listed and over-the-counter put and call options on securities (including securities of investment companies and baskets of securities), indices, and other financial instruments; purchase and sell financial futures contracts and options thereon; enter into various interest rate transactions, such as swaps, caps, floors or collars or credit transactions; equity index, total return and credit default swaps; forward contracts; and structured investments. In addition, the Fund may enter into various currency transactions, such as forward currency contracts, currency futures contracts, currency swaps or options on currency or currency futures. The Fund also may purchase and sell derivative instruments that combine features of these instruments. The Fund may invest in other types of derivatives, structured and similar instruments which are not currently available but which may be developed in the future.
The Fund may buy and sell shares of Portfolio Funds to take advantage of potential short-term trading opportunities, but short-term trading will not be used as the primary means of achieving the Fund’s investment objective.
Temporary Defensive Positions. When the investment manager believes that market or general economic conditions justify a temporary defensive position, the Fund may deviate from its investment objectives and invest all or any portion of its assets in investment grade debt securities. In such a case, the Fund may not pursue or achieve its investment objective.
The information contained in this notice is provided for informational purposes only and does not constitute a solicitation of an offer to buy or sell Fund shares.
For more information, please visit our website at www.cohenandsteers.com or call (866) 227-0757.
Website: https://www.cohenandsteers.com/
Symbols: (NYSE: CNS, FOF)
View original content:https://www.prnewswire.com/news-releases/cohen–steers-closed-end-opportunity-fund-inc-issues-important-notice-regarding-change-in-investment-policy-and-investment-strategy-302838246.html
SOURCE Cohen & Steers, Inc.
Technology
Shoulder Innovations to Participate in the Canaccord Genuity 46th Annual Growth Conference
Published
42 minutes agoon
July 29, 2026By
GRAND RAPIDS, Mich., July 29, 2026 /PRNewswire/ — Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that members of management will present at the Canaccord Genuity 46th Annual Growth Conference. The presentation will take place at 1:30 p.m. ET / 10:30 a.m. PT on Wednesday, August 12, 2026.
A live and archived webcast of the event will be available in the “Investor Relations” section of the Shoulder Innovations website at https://ir.shoulderinnovations.com/.
About Shoulder Innovations
Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations’ ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations’ ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.
Contact
Brian Johnston or Sam Bentzinger
Gilmartin Group LLC
ir@shoulderinnovations.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/shoulder-innovations-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference-302838112.html
SOURCE Shoulder Innovations
Technology
Lam Research Corporation Reports Financial Results for the Quarter Ended June 28, 2026
Published
42 minutes agoon
July 29, 2026By
FREMONT, Calif., July 29, 2026 /PRNewswire/ — Lam Research Corporation (the “Company,” “Lam,” “Lam Research”) today announced financial results for the quarter ended June 28, 2026 (the “June 2026 quarter”).
Highlights for the June 2026 quarter were as follows:
Revenue of $6.72 billion.U.S. GAAP gross margin as a percent of revenue of 51.7%, U.S. GAAP operating margin as a percent of revenue of 37.4%, and U.S. GAAP diluted EPS of $1.81.Non-GAAP gross margin as a percent of revenue of 52.0%, non-GAAP operating margin as a percent of revenue of 38.4%, and non-GAAP diluted EPS of $1.82.
Key Financial Data for the Quarters Ended
June 28, 2026 and March 29, 2026
(in thousands, except per-share data, percentages, and basis points)
U.S. GAAP
June 2026
March 2026
Change Q/Q
Revenue
$ 6,722,238
$ 5,841,488
+15.1 %
Gross margin
51.7 %
49.8 %
+ 190 bps
Operating margin
37.4 %
35.0 %
+ 240 bps
Diluted EPS
$ 1.81
$ 1.45
+24.8 %
Non-GAAP
June 2026
March 2026
Change Q/Q
Revenue
$ 6,722,238
$ 5,841,488
+15.1 %
Gross margin
52.0 %
49.9 %
+ 210 bps
Operating margin
38.4 %
35.0 %
+ 340 bps
Diluted EPS
$ 1.82
$ 1.47
+23.8 %
U.S. GAAP Financial Results
For the June 2026 quarter, revenue was $6.72 billion, gross margin was $3.48 billion, or 51.7% of revenue, operating expenses were $965.3 million, operating margin was 37.4% of revenue, and net income was $2.28 billion, or $1.81 per diluted share on a U.S. GAAP basis. This compares to revenue of $5.84 billion, gross margin of $2.91 billion, or 49.8% of revenue, operating expenses of $863.5 million, operating margin of 35.0% of revenue, and net income of $1.83 billion, or $1.45 per diluted share, for the quarter ended March 29, 2026 (the “March 2026 quarter”).
Non-GAAP Financial Results
For the June 2026 quarter, non-GAAP gross margin was $3.50 billion, or 52.0% of revenue, non-GAAP operating expenses were $916.4 million, non-GAAP operating margin was 38.4% of revenue, and non-GAAP net income was $2.28 billion, or $1.82 per diluted share. This compares to non-GAAP gross margin of $2.91 billion, or 49.9% of revenue, non-GAAP operating expenses of $866.2 million, non-GAAP operating margin of 35.0% of revenue, and non-GAAP net income of $1.85 billion, or $1.47 per diluted share, for the March 2026 quarter.
“Lam delivered record revenue, operating margin and earnings per share in the June quarter as AI-driven demand continues to reshape the semiconductor industry,” said Tim Archer, Lam Research’s President and Chief Executive Officer. “Our strategic investments and technology leadership are helping customers accelerate through rising manufacturing complexity, positioning Lam for a third consecutive year of outperformance in 2026.”
Balance Sheet and Cash Flow Results
Cash, cash equivalents, and restricted cash balances increased to $5.60 billion at the end of the June 2026 quarter compared to $4.77 billion at the end of the March 2026 quarter. The increase was primarily driven by cash generated from operating activities, partially offset by cash deployed for capital return activities during the quarter.
Deferred revenue at the end of the June 2026 quarter increased to $2.43 billion compared to $2.22 billion as of the end of the March 2026 quarter. Lam’s deferred revenue balance does not include shipments to customers in Japan, to whom title does not transfer until customer acceptance. Shipments to customers in Japan are classified as inventory at cost until the time of acceptance. The estimated future revenue from shipments to customers in Japan was approximately $490.2 million as of June 28, 2026 and $434.3 million as of March 29, 2026.
Revenue
The geographic distribution of revenue during the June 2026 quarter is shown in the following table:
Region
Revenue
Taiwan
27 %
China
26 %
Korea
20 %
Japan
9 %
United States
9 %
Southeast Asia
5 %
Europe
4 %
The following table presents revenue disaggregated between systems and customer support-related revenue:
Three Months Ended
June 28,
2026
March 29,
2026
June 29,
2025
(In thousands)
Systems revenue
$ 4,249,848
$ 3,730,582
$ 3,437,625
Customer support-related revenue and other
2,472,390
2,110,906
1,733,768
$ 6,722,238
$ 5,841,488
$ 5,171,393
Systems revenue includes sales of new leading-edge equipment in deposition, etch and other wafer fabrication markets.
Customer support-related revenue includes sales of customer service, spares, upgrades, and non-leading-edge equipment from our Reliant® product line.
Outlook
For the quarter ended September 27, 2026, Lam is providing the following guidance:
U.S. GAAP
Reconciling
Items
Non-GAAP
Revenue
$8.10 Billion
+/-
$400 Million
—
$8.10 Billion
+/-
$400 Million
Gross margin
52.0 %
+/-
1 %
$ 2.7
Million
52.0 %
+/-
1 %
Operating margin
39.5 %
+/-
1 %
$ 3.0
Million
39.5 %
+/-
1 %
Net income per diluted share
$2.15
+/-
$0.15
$ 3.3
Million
$2.15
+/-
$0.15
Diluted share count
1.255 Billion
—
1.255 Billion
The information provided above is only an estimate of what the Company believes is realizable as of the date of this release and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, restructuring, balance sheet valuation adjustments, financing arrangements, other investments, or other items that may be completed or realized after the date of this release, except as described below. U.S. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:
Gross margin – amortization related to intangible assets acquired through business combinations, $2.7 million.Operating margin – amortization related to intangible assets acquired through business combinations, $3.0 million.Net income per diluted share – amortization related to intangible assets acquired though business combinations, $3.0 million; amortization of debt discounts, $0.5 million; and associated tax benefit for non-GAAP items ($0.2 million); totaling $3.3 million.
Use of Non-GAAP Financial Results
In addition to U.S. GAAP results, this press release also contains non-GAAP financial results. The Company’s non-GAAP results for both the June 2026 and March 2026 quarters exclude amortization related to intangible assets acquired through business combinations, the effects of elective deferred compensation-related assets and liabilities, amortization of note discounts, workforce optimization charges, and the net income tax effect of non-GAAP items.
Management uses non-GAAP gross margin, operating expense, operating income, operating margin, net income, and net income per diluted share to evaluate the Company’s operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors’ ability to view the Company’s results from management’s perspective. Tables presenting reconciliations of non-GAAP results to U.S. GAAP results are included at the end of this press release and on the Company’s website at https://investor.lamresearch.com.
Caution Regarding Forward-Looking Statements
Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to: our outlook and guidance for future financial results, including revenue, gross margin, operating margin, net income per diluted share, and diluted share count; the effect of AI-driven demand on the semiconductor industry; the rising complexity of semiconductor manufacturing and the extent to which our investments and technology leadership help customers; and our positioning for outperformance. Some factors that may affect these forward-looking statements include: business, economic, political and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; the actions of our customers and competitors may be inconsistent with our expectations; trade regulations, export controls, tariffs, trade disputes, and other geopolitical tensions may inhibit our ability to sell our products; supply chain cost increases, tariffs, export controls and other inflationary pressures have impacted and may continue to impact our profitability; supply chain disruptions, export controls or manufacturing capacity constraints may limit our ability to manufacture and sell our products; and natural and human-caused disasters, disease outbreaks, war, terrorism, political or governmental unrest or instability, or other events beyond our control may impact our operations and revenue in affected areas; as well as the other risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the Risk Factors described in our most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. These uncertainties and changes could materially affect the forward-looking statements and cause actual results to vary from expectations in a material way. The Company undertakes no obligation to update the information or statements made in this release.
Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam’s equipment and services allow customers to build smaller and better performing devices. In fact, today, nearly every advanced chip is built with Lam technology. We combine superior systems engineering, technology leadership, and a strong values-based culture, with an unwavering commitment to our customers. Lam Research (Nasdaq: LRCX) is a FORTUNE 500® company headquartered in Fremont, Calif., with operations around the globe. Learn more at www.lamresearch.com. (LRCX)
Consolidated Financial Tables Follow.
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data and percentages)
Three Months Ended
Twelve Months Ended
June 28,
2026
March 29,
2026
June 29,
2025
June 28,
2026
June 29,
2025
(unaudited)
(unaudited)
(unaudited)
(unaudited)
(1)
Revenue
$ 6,722,238
$ 5,841,488
$ 5,171,393
$ 23,232,690
$ 18,435,591
Cost of goods sold
3,243,498
2,930,961
2,581,684
11,507,382
9,456,532
Gross margin
3,478,740
2,910,527
2,589,709
11,725,308
8,979,059
Gross margin as a percent of revenue
51.7 %
49.8 %
50.1 %
50.5 %
48.7 %
Research and development
642,922
583,200
580,178
2,375,873
2,096,387
Selling, general and administrative
322,330
280,311
268,403
1,149,640
981,704
Total operating expenses
965,252
863,511
848,581
3,525,513
3,078,091
Operating income
2,513,488
2,047,016
1,741,128
8,199,795
5,900,968
Operating margin
37.4 %
35.0 %
33.7 %
35.3 %
32.0 %
Other income (expense), net
41,654
(35,460)
37,853
62,678
57,161
Income before income taxes
2,555,142
2,011,556
1,778,981
8,262,473
5,958,129
Income tax expense
(277,860)
(186,096)
(58,893)
(997,077)
(599,912)
Net income
$ 2,277,282
$ 1,825,460
$ 1,720,088
$ 7,265,396
$ 5,358,217
Net income per share:
Basic
$ 1.82
$ 1.46
$ 1.35
$ 5.79
$ 4.17
Diluted
$ 1.81
$ 1.45
$ 1.35
$ 5.76
$ 4.15
Number of shares used in per share calculations:
Basic
1,251,286
1,249,728
1,274,279
1,255,079
1,286,101
Diluted
1,256,032
1,257,325
1,276,933
1,261,102
1,290,142
Cash dividend declared per common share
$ 0.26
$ 0.26
$ 0.23
$ 1.04
$ 0.92
(1)
Derived from audited financial statements
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
June 28,
2026
March 29,
2026
June 29,
2025
(unaudited)
(unaudited)
(1)
ASSETS
Cash and cash equivalents
$ 5,579,171
$ 4,750,936
$ 6,390,659
Accounts receivable, net
5,339,682
4,132,890
3,378,071
Inventories
4,276,111
3,999,992
4,307,991
Prepaid expenses and other current assets
415,741
413,099
440,274
Total current assets
15,610,705
13,296,917
14,516,995
Property and equipment, net
2,956,472
2,853,614
2,428,744
Goodwill and intangible assets
1,895,859
1,882,017
1,808,685
Other assets
3,066,707
2,759,362
2,590,836
Total assets
$ 23,529,743
$ 20,791,910
$ 21,345,260
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current portion of long-term debt and finance lease obligations
$ 4,073
$ 4,095
$ 754,311
Other current liabilities
5,933,176
5,238,303
5,814,114
Total current liabilities
5,937,249
5,242,398
6,568,425
Long-term debt and finance lease obligations
3,730,490
3,730,384
3,730,194
Income taxes payable
681,197
621,572
603,412
Other long-term liabilities
709,886
612,777
581,610
Total liabilities
11,058,822
10,207,131
11,483,641
Stockholders’ equity (2)
12,470,921
10,584,779
9,861,619
Total liabilities and stockholders’ equity
$ 23,529,743
$ 20,791,910
$ 21,345,260
(1)
Derived from audited financial statements
(2)
Common shares issued and outstanding were 1,251,278 as of June 28, 2026, 1,250,539 as of March 29, 2026, and 1,268,740 as of June 29, 2025
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
Three Months Ended
Twelve Months Ended
June 28,
2026
March 29,
2026
June 29,
2025
June 28,
2026
June 29,
2025
(unaudited)
(unaudited)
(unaudited)
(unaudited)
(1)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income
$ 2,277,282
$ 1,825,460
$ 1,720,088
$ 7,265,396
$ 5,358,217
Adjustments to reconcile net income to net cash provided by
operating activities:
Depreciation and amortization
119,642
116,322
98,439
441,533
386,277
Deferred income taxes
(175,752)
(19,478)
(151,679)
(289,062)
(363,247)
Equity-based compensation expense
103,985
96,616
94,286
386,381
343,371
Other, net
(8,006)
(2,855)
14,240
(32,712)
6,845
Changes in operating assets and liabilities
(859,923)
(874,645)
778,814
(1,913,879)
441,801
Net cash provided by operating activities
1,457,228
1,141,420
2,554,188
5,857,657
6,173,264
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets
(188,801)
(331,604)
(172,191)
(966,405)
(759,186)
Other, net
45,060
(2,976)
42,940
44,253
51,094
Net cash used for investing activities
(143,741)
(334,580)
(129,251)
(922,152)
(708,092)
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on debt, including finance lease
obligations and payments for debt issuance costs
(1,355)
(751,194)
(1,485)
(755,428)
(507,488)
Treasury stock purchases, including excise tax payments
(246,560)
(1,162,837)
(1,292,277)
(3,851,343)
(3,422,321)
Dividends paid
(325,318)
(325,829)
(295,207)
(1,270,635)
(1,149,542)
Reissuance of treasury stock related to employee stock
purchase plan
88,780
—
79,556
155,965
140,113
Proceeds from issuance of common stock
4,426
9,167
696
17,447
2,452
Other, net
(282)
55
(820)
(13,793)
143
Net cash used for financing activities
(480,309)
(2,230,638)
(1,509,537)
(5,717,787)
(4,936,643)
Effect of exchange rate changes on cash, cash equivalents,
and restricted cash
(2,056)
(4,979)
29,284
(27,431)
28,324
Net change in cash, cash equivalents, and restricted cash
831,122
(1,428,777)
944,684
(809,713)
556,853
Cash, cash equivalents, and restricted cash at beginning of
period (2)
4,766,821
6,195,598
5,462,972
6,407,656
5,850,803
Cash, cash equivalents, and restricted cash at end of period
(2)
$ 5,597,943
$ 4,766,821
$ 6,407,656
$ 5,597,943
$ 6,407,656
(1)
Derived from audited financial statements
(2)
Restricted cash is reported within Other assets in the Condensed Consolidated Balance Sheets
Non-GAAP Financial Summary
(in thousands, except percentages and per share data)
(unaudited)
Three Months Ended
June 28,
2026
March 29,
2026
Revenue
$ 6,722,238
$ 5,841,488
Gross margin
$ 3,497,336
$ 2,913,123
Gross margin as percent of revenue
52.0 %
49.9 %
Operating expenses
$ 916,420
$ 866,166
Operating income
$ 2,580,916
$ 2,046,957
Operating margin
38.4 %
35.0 %
Net income
$ 2,279,968
$ 1,851,442
Net income per diluted share
$ 1.82
$ 1.47
Shares used in per share calculation – diluted
1,256,032
1,257,325
Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income
(in thousands, except per share data)
(unaudited)
Three Months Ended
June 28,
2026
March 29,
2026
U.S. GAAP net income
$ 2,277,282
$ 1,825,460
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations – cost of goods sold
2,668
2,668
Elective deferred compensation (“EDC”) related liability valuation increase (decrease) – cost of goods sold
15,379
(6,476)
Workforce optimization charges – cost of goods sold
549
6,404
EDC related liability valuation increase (decrease) – research and development
27,682
(11,656)
Workforce optimization charges – research and development
960
9,437
Amortization related to intangible assets acquired through certain business combinations – selling, general and
administrative
348
348
EDC related liability valuation increase (decrease) – selling, general and administrative
18,454
(7,771)
Workforce optimization charges – selling, general and administrative
1,388
6,987
Amortization of note discounts – other income (expense), net
504
674
(Gain) loss on EDC related asset – other income (expense), net
(61,325)
27,265
Net income tax benefit on non-GAAP items
(3,921)
(1,898)
Non-GAAP net income
$ 2,279,968
$ 1,851,442
Non-GAAP net income per diluted share
$ 1.82
$ 1.47
U.S. GAAP net income per diluted share
$ 1.81
$ 1.45
U.S. GAAP and non-GAAP number of shares used for per diluted share calculation
1,256,032
1,257,325
Reconciliation of U.S. GAAP Gross Margin, Operating Expenses, Operating Income and Operating Margin to Non-GAAP
Gross Margin, Operating Expenses, Operating Income and Operating Margin
(in thousands, except percentages)
(unaudited)
Three Months Ended
June 28,
2026
March 29,
2026
U.S. GAAP gross margin
$ 3,478,740
$ 2,910,527
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations
2,668
2,668
EDC related liability valuation increase (decrease)
15,379
(6,476)
Workforce optimization charges
549
6,404
Non-GAAP gross margin
$ 3,497,336
$ 2,913,123
U.S. GAAP gross margin as a percent of revenue
51.7 %
49.8 %
Non-GAAP gross margin as a percent of revenue
52.0 %
49.9 %
U.S. GAAP operating expenses
$ 965,252
$ 863,511
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations
(348)
(348)
EDC related liability valuation (increase) decrease
(46,136)
19,427
Workforce optimization charges
(2,348)
(16,424)
Non-GAAP operating expenses
$ 916,420
$ 866,166
U.S. GAAP operating income
$ 2,513,488
$ 2,047,016
Non-GAAP operating income
$ 2,580,916
$ 2,046,957
U.S. GAAP operating margin
37.4 %
35.0 %
Non-GAAP operating margin
38.4 %
35.0 %
Lam Research Corporation Contact:
Ram Ganesh, Investor Relations, phone: 510-572-1615, e-mail: investor.relations@lamresearch.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/lam-research-corporation-reports-financial-results-for-the-quarter-ended-june-28-2026-302838154.html
SOURCE Lam Research Corporation
HAMILTON BEACH BRANDS HOLDING COMPANY ANNOUNCES DATES OF ITS 2026 SECOND QUARTER EARNINGS RELEASE AND CONFERENCE CALL
Cohen & Steers Closed-end Opportunity Fund, Inc. Issues Important Notice Regarding Change in Investment Policy and Investment Strategy
Shoulder Innovations to Participate in the Canaccord Genuity 46th Annual Growth Conference
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
New Gooseneck Omni Antennas Offer Enhanced Signals in a Durable Package
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Coin Market5 days agoStrive’s SATA recovers most of June decline, trades within 3% of par
-
Coin Market5 days agoEthereum ETFs close week in red, end 5-day inflow streak
-
Technology4 days agoTony Jaa Becomes GAC’s 30-Millionth Customer – GAC Wins Global Trust with “True Craftsmanship”
-
Coin Market4 days agoBitcoin advocacy group to join US State Department’s ‘digital freedom’ program
-
Technology5 days agoPortland General Electric declares dividend
-
Technology5 days agoHyundai Motor Group Executive Chair Euisun Chung Announces Physical AI Vision at San Francisco AI Summit
-
Coin Market4 days agoBinance ‘red teams’ its own staff every month to keep hackers out
-
Technology3 days agoAnX Robotica Launches NaviCONNECT™: Connecting the Future of Capsule Endoscopy
